Drug repurposing to target TGF-β in chemoresistant high-grade serous ovarian cancer

被引：0
|
作者：
Wong-Brown, Michelle W. Y.
Johnson, Zlata
Salem, Saad
Matthews, Bayley G.
Ford, Caroline E.
Marsh, Deborah J.
Bowden, Nikola A.
机构：
来源：
MOLECULAR CANCER THERAPEUTICS | 2023年 / 22卷 / 12期
关键词：
D O I：
10.1158/1535-7163.TARG-23-C041
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
C041
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Repurposing simvastatin to inhibit the mevalonate pathway as a therapeutic strategy to treat high-grade serous ovarian cancer
    Pereira, Madison
    Matuszewska, Kathy
    Haagsma, Jacob
    Glogova, Alice
    Shepherd, Trevor G.
    Petrik, Jim
    CANCER RESEARCH, 2022, 82 (12)
  • [22] Neurotensin signaling pathway as a potential therapeutic target in high-grade serous ovarian cancer
    Norris, E. J.
    DeStephanis, D.
    Zhang, Q.
    Tait, D. L.
    Ganapathi, R.
    Ganapathi, M.
    GYNECOLOGIC ONCOLOGY, 2018, 149 : 71 - 71
  • [23] Antineoplastic Drug Synergy of Artesunate with Navitoclax in Models of High-Grade Serous Ovarian Cancer
    McCorkle, J. Robert
    Ahn, Rebecca
    Cao, Connie D.
    Hill, Kristen S.
    Dietrich, Charles S.
    Kolesar, Jill M.
    CANCERS, 2024, 16 (07)
  • [24] Drug resistance in end-stage high-grade serous ovarian cancer.
    Christie, Elizabeth L.
    Alsop, Kathryn
    Au-Yeung, George
    Pandey, Ahwan
    Bowtell, David D. L.
    CLINICAL CANCER RESEARCH, 2020, 26 (13) : 17 - 17
  • [25] Effect of fibroblast heterogeneity on prognosis and drug resistance in high-grade serous ovarian cancer
    Wang, Tingjie
    Tian, Lingxi
    Wei, Bing
    Li, Jun
    Zhang, Cuiyun
    Long, Ruitao
    Zhu, Xiaofei
    Zhang, Yougai
    Wang, Bo
    Tang, Guangbo
    Yang, Jun
    Guo, Yongjun
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [26] Repurposing the anti-rheumatic gold compound auranofin for high-grade serous ovarian cancer therapy.
    Abdalbari, Farah H.
    Goyeneche, Alicia A.
    Martinez-Jaramillo, Elvis
    Sabri, Siham
    Telleria, Carlos M.
    CANCER RESEARCH, 2021, 81 (13)
  • [27] Principles of dormancy evident in high-grade serous ovarian cancer
    Trevor G. Shepherd
    Frederick A. Dick
    Cell Division, 17
  • [28] The peritoneal tumour microenvironment of high-grade serous ovarian cancer
    Leinster, D. Andrew
    Kulbe, Hagen
    Everitt, Gemma
    Thompson, Richard
    Perretti, Mauro
    Gavins, Felicity N. E.
    Cooper, Dianne
    Gould, David
    Ennis, Darren P.
    Lockley, Michelle
    McNeish, Iain A.
    Nourshargh, Sussan
    Balkwill, Frances R.
    JOURNAL OF PATHOLOGY, 2012, 227 (02): : 136 - 145
  • [29] Centrosomes - The Achilles' heel of high-grade serous ovarian cancer?
    Chandrasekaran, G.
    Hall, D.
    Vias, M.
    Brenton, J. D.
    Gergely, F.
    MOLECULAR BIOLOGY OF THE CELL, 2015, 26
  • [30] Determinants of resistance and response in high-grade serous ovarian cancer
    Bowtell, David D. L.
    CLINICAL CANCER RESEARCH, 2016, 22
12345